期刊文献+

奥美沙坦对大鼠移植静脉内膜重构过程中整合素β-3/FAK信号蛋白表达的影响

Expression of integrin β-3/focal adhesion kinase on intimal remodeling of rat vein graft: modulation by olmesartan
下载PDF
导出
摘要 目的:观察奥美沙坦对大鼠移植静脉内膜重构过程中整合素β-3(integrinβ-3)黏着斑激酶(focal adhesion kinase,FAK)表达的影响。方法:建立大鼠移植静脉桥模型,将36只雄性SD大鼠被随机分成模型对照组、奥美沙坦组及生理盐水对照组,每组12只。取移植静脉切片、HE染色观察各组血管壁内膜的厚度。采用免疫组化染色法观察各组血管平滑肌细胞(SMC)增殖核抗原(PCNA)的表达。采用Western blot法检测整合素β-3和FAK的表达。结果:与模型对照组相比,奥美沙坦组内膜的厚度明显减轻(P<0.05);PCNA和FAK的表达明显降低(P<0.05)。生理盐水对照组与模型对照组相比,内膜的厚度无明显减轻;PCNA和FAK的表达无明显改变。结论:大鼠移植静脉内膜重构过程中,伴随整合素β-3/FAK信号蛋白的表达,奥美沙坦可抑制大鼠移植静脉内膜重构,此作用可能与下调FAK信号蛋白的表达有关。 AIM: To observe the expression of focal adhesion kinase in rat's autologous vein graft and its modulating effect by olmesartan (a specific type Ⅰ angiotensin Ⅱ receptor antagonist). METHODS: Autologous external jugular veins were grafted to common carotid arteries in 36 male Wistar rats. After surgery, rats were randomly assigned to three groups (12 rats in each) : model control group, olmesartan group and physiological saline group. The intimal thickness in vein grafts was quantitated in H/E-stained segments. Integrin β-3 and focal adhesion kinase expression levels were assessed by Western blotting, and proliferating cell nuclear antigen (PCNA) was measured by immunohistochemistry. RESULTS: Neointimal hyperplasia was observed in model control group characterized by significant intimal thickening. The expressions of integrin β-3, FAK and PCNA were positive in model control group. Compared with that in model control group, the intimal thickness was significantly attenuated in olmesartan group (P 〈 0. 05 ) and the expressions of FAK and PCNA significantly reduced (P 〈 0. 05 ). CONCLUSION : FAK is involved in the restenosis of vein graft in rats. Olmesartan attenuates the restenosis of rat vein graft, possibly through its downregulating effect on FAK.
出处 《心脏杂志》 CAS 2010年第2期164-167,共4页 Chinese Heart Journal
关键词 奥关沙坦 重构 黏着斑激酶 olmesartan remodeling focal adhesion kinase
  • 相关文献

参考文献13

  • 1兰锡纯 冯卓荣.心脏血管外科学[M].北京:人民卫生出版社,2002.1 025-1034.
  • 2Yoshida Y, Mitsumata M, Ling G, et al. Migration of medial smooth muscle cells to the intirna after balloon injury[ J ]. Ann N Y Acad Sci, 1997, 8 ( 11 ) :459 - 470.
  • 3温进坤,韩梅,程云会,杨长春,刘智敏.整合素β_3-粘着斑激酶信号途径的活化参与大鼠血管新生内膜的形成[J].中国病理生理杂志,2006,22(10):1922-1925. 被引量:5
  • 4Yau JM, Alexander JH, Harley G, et al. Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of ex-vivo Vein graft ENgineering via Transfection [ J ]. Am J Cardiol, 2008, 102 (5) : 546 - 551.
  • 5Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system[ J ]. Am J Physiol Cell Physiol, 2007, 292( 1 ) :C82 - C97.
  • 6Furubayashi K, Takai S, Jin D, et al. The significance of chymase in the progression nf abdominal aortic aneurysms in dogs [ J ]. Hypertens Res, 2007, 30(4) :349 -357.
  • 7Govindarajan G, Ehle DM, Lucehesi PA, et al. Focal adhesion kinase is involved in angiotensin ll-mediated prulein synthesis in cultured vascular smooth muscle cells[J]. Circuhltion Res, 2000, 87(8) :710 - 716.
  • 8Zannad F, Fay R. Blood pressure-lowering efficacy of olmesartan relative to other angiotensin II receptor antagonists: an overview of randonrized eontrolled studies [ J ]. Fundam Cliu Pharmacol, 2007, 21 (2) :181 - 190.
  • 9Mizuno M, SadaT, Ikeda M, et al. Pharmacolog3 of CS-866, a novel nonpeptide angiotensinⅡ receptor antagonist [ J ]. Eur J Pharmacol, 1995, 285(2) :181 -188.
  • 10Koike H, Sada T, Mizuno M. In vitro and in vivo pharmacology of olmesartan medoxomil, an angiotensin Ⅱ type ATlreceptor antagonist [J]. J Hypertens Suppl, 2001, 19( 1 ) :S3 - S14.

二级参考文献11

  • 1Raines EW, Koyama H, Carragher NO. The extracellular matrix dynamically regulates smooth muscle cell responsiveness to PDGF[J]. Ann N Y Acad Sci, 2000, 902:39-51.
  • 2Wen JK, Han M, Zheng B. et al. Comparison of gene expression patterns and migration capability at quiescent and proliferating vascular smooth muscle cells stimulated by cytokines[J]. Life Sci, 2002, 70(7) : 799 -807.
  • 3Liaw L, Skinner MP, Raines EW, et al. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface intergrins[ J]. J Clin Invest, 1995, 95(2) : 713 -724.
  • 4Zheng B, Wen JK, Han M, et al. hhLIM protein is involved in cardiac hypertrophy[ J]. Biochim Biophys Acta,2004, 1690( 1 ) : 1 - 10.
  • 5Ohlstein EH, Douglas SA, Sung CP, et al. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury[J]. Proc Natl Acad Sci USA, 1993,90(13) : 6189 -6193.
  • 6Ingber DE. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physlology[J]. Circ Res, 2002, 91( 10): 877-887.
  • 7Wolf C, Cai W J, Vosschulte R, et al. Vascular remodeling and altered protein expression during growth of coronary collateral arteries[ J]. J Mol Cell Cardiol, 1998, 30( 11 ) : 2291 - 2305.
  • 8Li Z, Froehlich J, Galls ZS, et al. Increased expression of matrix metalloproteinase -2 in the thickened intima of aged rats[J]. Hypertension, 1999, 33(1 ) : 116 - 123.
  • 9周秀霞,温进坤,韩梅.血管再狭窄发生过程中MMP-2基因表达与胶原转换的动态变化[J].中国生物化学与分子生物学报,1999,15(6):997-1001. 被引量:27
  • 10刘虹彬,温进坤,韩梅.氧化型低密度脂蛋白对大鼠血管平滑肌细胞基质金属蛋白酶-2和9表达的影响[J].中国动脉硬化杂志,2001,9(1):10-13. 被引量:23

共引文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部